XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.25.3

EQUITY (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Stockholders' Equity Note [Abstract] |
Schedule of Changes In Consolidated Equity | The following tables present the changes in consolidated equity (dollars in millions, share amounts in thousands):
|  | Common Stock |  | Additional Paid-In Capital |  | Accumulated Other Comprehensive Loss |  | Retained Earnings |  | Treasury Stock |  | Noncontrolling Interests |  | Total Equity |  |  |  |
|  | Shares Outstanding |  | Issued Par Amount |  |  |  |  |  |  |  |  |  |
Balances at December 31, 2024 |  | 95,109 |  |  | $ | 8 |  |  | $ | 4,873 |  |  | $ | (180) |  |  | $ | 3,008 |  |  | $ | (3,538) |  |  | $ | 1,649 |  |  | $ | 5,820 |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 406 |  |  | — |  |  | 95 |  |  | 501 |  |  |  |  |
Distributions paid to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (89) |  |  | (89) |  |  |  |  |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  |  |  |
Net purchases (sales) of businesses and noncontrolling interests |  | — |  |  | — |  |  | (35) |  |  | — |  |  | — |  |  | — |  |  | 41 |  |  | 6 |  |  |  |  |
Repurchases of common stock |  | (2,629) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (351) |  |  | — |  |  | (351) |  |  |  |  |
Stock-based compensation expense, tax benefit and issuance of common stock |  | 405 |  |  | — |  |  | (12) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (12) |  |  |  |  |
Balances at March 31, 2025 |  | 92,885 |  |  | 8 |  |  | 4,826 |  |  | (178) |  |  | 3,414 |  |  | (3,889) |  |  | 1,696 |  |  | 5,877 |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 288 |  |  | — |  |  | 105 |  |  | 393 |  |  |  |  |
Distributions paid to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (83) |  |  | (83) |  |  |  |  |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  |  |  |
Net purchases of businesses and noncontrolling interests |  | — |  |  | — |  |  | 10 |  |  | — |  |  | — |  |  | — |  |  | 9 |  |  | 19 |  |  |  |  |
Repurchases of common stock |  | (4,601) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (753) |  |  | — |  |  | (753) |  |  |  |  |
Stock-based compensation expense, tax benefit and issuance of common stock |  | 60 |  |  | — |  |  | 22 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 22 |  |  |  |  |
Balances at June 30, 2025 |  | 88,344 |  |  | 8 |  |  | 4,858 |  |  | (177) |  |  | 3,702 |  |  | (4,642) |  |  | 1,727 |  |  | 5,476 |  |  |  |  |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 342 |  |  | — |  |  | 106 |  |  | 448 |  |  |  |  |
Distributions paid to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (102) |  |  | (102) |  |  |  |  |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | 3 |  |  | — |  |  | — |  |  | — |  |  | 3 |  |  |  |  |
Purchases (sales) of businesses and noncontrolling interests, net |  | — |  |  | — |  |  | (9) |  |  | — |  |  | — |  |  | — |  |  | 38 |  |  | 29 |  |  |  |  |
Repurchases of common stock |  | (598) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (94) |  |  | — |  |  | (94) |  |  |  |  |
Stock-based compensation expense, tax benefit and issuance of common stock |  | 121 |  |  | — |  |  | 23 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 23 |  |  |  |  |
Balances at September 30, 2025 |  | 87,867 |  |  | $ | 8 |  |  | $ | 4,872 |  |  | $ | (174) |  |  | $ | 4,044 |  |  | $ | (4,736) |  |  | $ | 1,769 |  |  | $ | 5,783 |  |  |  |  |
|  | Common Stock |  | Additional Paid-In Capital |  | Accumulated Other Comprehensive Loss |  | Retained Earnings (Accumulated Deficit) |  | Treasury Stock |  | Noncontrolling Interests |  | Total Equity
|  | Shares Outstanding |  | Issued Par Amount |  |  |  |  |  |
Balances at December 31, 2023 |  | 99,950 |  |  | $ | 8 |  |  | $ | 4,834 |  |  | $ | (181) |  |  | $ | (192) |  |  | $ | (2,861) |  |  | $ | 1,509 |  |  | $ | 3,117 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,151 |  |  | — |  |  | 82 |  |  | 2,233 |
Distributions paid to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (78) |  |  | (78) |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | 2 |
Net sales of businesses and noncontrolling interests |  | — |  |  | — |  |  | (5) |  |  | — |  |  | — |  |  | — |  |  | (23) |  |  | (28) |
Repurchases of common stock |  | (2,811) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (280) |  |  | — |  |  | (280) |
Stock-based compensation expense, tax benefit and issuance of common stock |  | 534 |  |  | — |  |  | (23) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (23) |
Balances at March 31, 2024 |  | 97,673 |  |  | 8 |  |  | 4,806 |  |  | (179) |  |  | 1,959 |  |  | (3,141) |  |  | 1,490 |  |  | 4,943 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 259 |  |  | — |  |  | 97 |  |  | 356 |
Distributions paid to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (70) |  |  | (70) |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | 2 |
Net purchases of businesses and noncontrolling interests |  | — |  |  | — |  |  | 12 |  |  | — |  |  | — |  |  | — |  |  | 64 |  |  | 76 |
Repurchases of common stock |  | (1,990) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (273) |  |  | — |  |  | (273) |
Stock-based compensation expense, tax benefit and issuance of common stock |  | 136 |  |  | — |  |  | 22 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 22 |
Balances at June 30, 2024 |  | 95,819 |  |  | 8 |  |  | 4,840 |  |  | (177) |  |  | 2,218 |  |  | (3,414) |  |  | 1,581 |  |  | 5,056 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 472 |  |  | — |  |  | 95 |  |  | 567 |
Distributions paid to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (79) |  |  | (79) |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | 2 |
Accretion of redeemable noncontrolling interests |  | — |  |  | — |  |  | (5) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5) |
Net sales of businesses and noncontrolling interests |  | — |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | — |  |  | (5) |  |  | (8) |
Repurchases of common stock |  | (795) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (124) |  |  | — |  |  | (124) |
Stock-based compensation expense, tax benefit and issuance of common stock |  | 59 |  |  | — |  |  | 17 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17 |
Balances at September 30, 2024 |  | 95,083 |  |  | $ | 8 |  |  | $ | 4,849 |  |  | $ | (175) |  |  | $ | 2,690 |  |  | $ | (3,538) |  |  | $ | 1,592 |  |  | $ | 5,426 |
Schedule of Changes in Redeemable Noncontrolling Interests in Equity of Consolidated Subsidiaries | The table below presents our nonredeemable noncontrolling interests balances by segment:
|  | September 30, 2025 |  | December 31, 2024
Hospital Operations |  | $ | 204 |  |  | $ | 205 |
Ambulatory Care |  | 1,565 |  |  | 1,444 |
Total nonredeemable noncontrolling interests |  | $ | 1,769 |  |  | $ | 1,649 |
The table below presents our income available to nonredeemable noncontrolling interests by segment:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Hospital Operations |  | $ | 9 |  |  | $ | 14 |  |  | $ | 33 |  |  | $ | 35 |
Ambulatory Care |  | 97 |  |  | 81 |  |  | 273 |  |  | 239 |
Total net income available to nonredeemable noncontrolling interests |  | $ | 106 |  |  | $ | 95 |  |  | $ | 306 |  |  | $ | 274 |
Schedule of Share Repurchase Activity | The table below presents repurchase activity under both the 2022 and 2024 share repurchase programs:
Period |  |  |  | Total Number of Shares Purchased |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Program |  | Maximum Dollar Value of Shares That May Yet Be Purchased Under the Program
|  |  |  | (In Thousands) |  |  |  | (In Thousands) |  | (In Millions)
Nine Months Ended September 30, 2025: |  |  |  |  |  |  |  |  |  |
January 1 through January 31, 2025 |  |  |  | — |  | $ | — |  |  | — |  | $ | 1,376 |
February 1 through February 28, 2025 |  |  |  | 1,800 |  | $ | 134.98 |  |  | 1,800 |  | $ | 1,133 |
March 1 through March 31, 2025 |  |  |  | 829 |  | $ | 126.67 |  |  | 829 |  | $ | 1,028 |
April 1 through April 30, 2025 |  |  |  | — |  | $ | — |  |  | — |  | $ | 1,028 |
May 1 through May 31, 2025 |  |  |  | 2,456 |  | $ | 157.57 |  |  | 2,456 |  | $ | 641 |
June 1 through June 30, 2025 |  |  |  | 2,145 |  | $ | 167.83 |  |  | 2,145 |  | $ | 281 |
July 1 through July 31, 2025 |  |  |  | 598 |  | $ | 155.43 |  |  | 598 |  | $ | 1,688 |
August 1 through August 31, 2025 |  |  |  | — |  | $ | — |  |  | — |  | $ | 1,688 |
September 1 through September 30, 2025 |  |  |  | — |  | $ | — |  |  | — |  | $ | 1,688 |
January 1 through September 30, 2025 |  |  |  | 7,828 |  | $ | 151.75 |  |  | 7,828 |  |
Nine Months Ended September 30, 2024: |  |  |  |  |  |  |  |  |  |
January 1 through January 31, 2024 |  |  |  | — |  | $ | — |  |  | — |  | $ | 550 |
February 1 through February 29, 2024 |  |  |  | — |  | $ | — |  |  | — |  | $ | 550 |
March 1 through March 31, 2024 |  |  |  | 2,811 |  | $ | 98.86 |  |  | 2,811 |  | $ | 272 |
April 1 through April 30, 2024 |  |  |  | — |  | $ | — |  |  | — |  | $ | 272 |
May 1 through May 31, 2024 |  |  |  | — |  | $ | — |  |  | — |  | $ | 272 |
June 1 through June 30, 2024 |  |  |  | 1,990 |  | $ | 135.85 |  |  | 1,990 |  | $ | 2 |
July 1 through July 31, 2024 |  |  |  | — |  | $ | — |  |  | — |  | $ | 1,500 |
August 1 through August 31, 2024 |  |  |  | — |  | $ | — |  |  | — |  | $ | 1,500 |
September 1 through September 30, 2024 |  |  |  | 795 |  | $ | 155.95 |  |  | 795 |  | $ | 1,376 |
January 1 through September 30, 2024 |  |  |  | 5,596 |  | $ | 120.07 |  |  | 5,596 |  |

X
- Definition Nonredeemable Noncontrolling Interest + References No definition available. + Details
Name: | thc_NonredeemableNoncontrollingInterestTableTextBlock
Namespace Prefix: | thc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1 + Details
Name: | us-gaap_ScheduleOfTreasuryStockByClassTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration